VA Funds $1.5M Study on MDMA Therapy for Veterans with PTSD and Alcohol Use Disorder

Dec 3, 2024, 05:54 PM

The U.S. Department of Veterans Affairs (VA) has announced its first study on psychedelic-assisted therapy since the 1960s, focusing on the potential of MDMA-assisted therapy to treat post-traumatic stress disorder (PTSD) and alcohol use disorder among veterans. The study, funded with $1.5 million, is a significant step towards exploring alternative treatments for conditions that disproportionately affect veterans. This initiative marks a notable shift in policy, as it is the first VA-funded study on psychedelics in over five decades, highlighting a growing interest in the therapeutic potential of psychedelics for mental health issues.